Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 20
Selected: 0
NCT IDTitle
NCT02567682Drug Interaction Study of GBT440 With Caffeine, S-warfarin, Omeprazole, and Midazolam in Healthy Subjects
NCT05780463MP0420 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)
NCT02989168Study to Evaluate the Effect of GBT440 Administered to Subjects With IPF on Supplemental Oxygen at Rest
NCT05780268LY3819253 (LY-CoV555) for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)
NCT05780424BRII-196/BRII-198 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)
NCT02497924A Study of the Absorption, Metabolism, and Excretion of GBT440 in Healthy Male Subjects
NCT02846324Study to Evaluate the Safety and Tolerability of GBT440 Administered to Subjects With IPF
NCT05780541PF-07304814 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)
NCT02567695A Single-Dose Relative Bioavailability Study Of GBT440 300 mg Capsules in Healthy Subjects
NCT04969250Vaccination for Recovered Inpatients With COVID-19 (VATICO)
NCT05780281VIR-7831 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)
NCT04335721A Voxelotor for Sickle Cell Anemia Patients at Highest Risk for Progression of Chronic Kidney Disease
NCT05780437AZD7442 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)
NCT03161015Single-Dose PK Study of GBT440 in Subjects With Renal Impairment
NCT02285088A Study of the Safety, Blood Levels and Biological Effects of GBT440 in Healthy Subjects and Subjects With Sickle Cell Disease
NCT04581356Voxelotor Sickle Cell Exercise Study
NCT04501978ACTIV-3: Therapeutics for Inpatients With COVID-19
NCT03051711Study to Evaluate Effects of Investigational Drug on Oxygenation in Healthy Volunteers Under Hypoxic Conditions
NCT04843761ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19
NCT03041909An Extension Study to Further Evaluate the Safety, Tolerability of GBT440 in Patients With Sickle Cell Disease Who Participated in the Study GBT440-001